Immunotherapy exposes cancer stem cell resistance and a new synthetic lethality

Molecular Therapy

Volumn 21, Issue 8, 2013, Pages 1472-1474

  Radvanyi, Laszlo ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYCLOPHOSPHAMIDE; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA VACCINE; DOXORUBICIN; ETOPOSIDE; GANCICLOVIR; INTERLEUKIN 17; NERVE CELL ADHESION MOLECULE; OXALIPLATIN; PARVOVIRUS VECTOR; PROSTATE ANTIGEN; PROTEIN P53; TOPOISOMERASE IIALPHA; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

CANCER IMMUNOTHERAPY; CANCER RESISTANCE; CANCER STEM CELL; DNA LIBRARY; EPITHELIAL MESENCHYMAL TRANSITION; LUNG NON SMALL CELL CANCER; MELANOMA; NONHUMAN; NOTE; OVERALL SURVIVAL; PROSTATE CANCER; PROSTATE TUMOR; TH1 CELL; TH17 CELL; TUMOR RECURRENCE; VESICULAR STOMATITIS VIRUS;

ANIMALS; ANTIGENS, NEOPLASM; HUMANS; MALE; NEOPLASMS;

EID: 84881301066     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2013.160     Document Type: Note

References (16)

1. Sullivan, RJ and Flaherty, KT (2013). Resistance to BRAF-targeted therapy in melanoma. Eur J Cancer 49: 1297-1304.
2. Matsushita, H, Vesely, MD, Koboldt, DC, Rickert, CG, Uppaluri, R, Magrini, VJ et al. (2012). Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting. Nature 482: 400-404.
3. Boisgerault, N, Kottke, T, Pulido, J, Thompson, J, Diaz, RM, Rommelfanger-Konkol, D et al. (2013). Functional cloning of recurrence-specific antigens identifies molecular targets to treat tumor relapse. Mol Ther 21: 1507-1516.
4. Kottke, T, Errington, F, Pulido, J, Galivo, F, Thompson, J, Wongthida, P et al. (2011). Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors. Nat Med 17: 854-859.
5. Pulido, J, Kottke, T, Thompson, J, Galivo, F, Wongthida, P, Diaz, RM et al. (2012). Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma. Nat Biotechnol 30: 337-343.
6. Koopman, G, Beenhakker, N, Hofman, S, Walther-Jallow, L, Mäkitalo, B, Mooij, P et al. (2012). Immunization with apoptotic pseudovirus transduced cells induces both cellular and humoral responses: A proof of concept study in macaques. Vaccine 30: 2523-2534.
7. Mire, CE, Miller, AD, Carville, A, Westmoreland, SV, Geisbert, JB, Mansfield, KG et al. (2012). Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primates. PLoS Negl Trop Dis 6: E1567.
8. Gilboa, E and Vieweg, J (2004). Cancer immunotherapy with mRNA-transfected dendritic cells. Immunol Rev 199: 251-263.
9. Liao, X, Li, Y, Bonini, C, Mair, S, Gilboa, E, Greenberg, PD et al. (2004). Transfection of RNA encoding tumor antigens following maturation of dendritic cells leads to prolonged presentation of antigen and the generation of high-affinity tumor-reactive cytotoxic T lymphocytes. Mol Ther 9: 757-764.
10. Kalluri, R (2009). EMT: When epithelial cells decide to become mesenchymal-like cells. J Clin Invest 119: 1417-1419.
11. Reim, F, Dombrowski, Y, Ritter, C, Buttmann, M, Häusler, S, Ossadnik, M et al. (2009). Immunoselection of breast and ovarian cancer cells with trastuzumab and natural killer cells: Selective escape of CD44high/CD24low/HER2low breast cancer stem cells. Cancer Res 69: 8058-8066.
12. Roesch, A, Vultur, A, Bogeski, I, Wang, H, Zimmermann, KM, Speicher, D et al. (2013). Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slowcycling JARID1B(high) Cells. Cancer Cell 23: 811-825.
13. Galluzzi, L, Senovilla, L, Zitvogel, L and Kroemer, G (2012). The secret ally: Immunostimulation by anticancer drugs. Nat Rev Drug Discov 11: 215-233.
14. Obeid, M, Tesniere, A, Ghiringhelli, F, Fimia, GM, Apetoh, L, Perfettini, JL et al. (2007). Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 13: 54-61.
15. Rowswell-Turner, RB, Harden, JL, Nair, RE, Gu, T, Kilinc, MO and Egilmez, NK (2011). Chronic chemoimmunotherapy achieves cure of spontaneous murine mammary tumors via persistent blockade of posttherapy counter-regulation. J Immunol 187: 4109-4118.
16. Chiappori, AA, Soliman, H, Janssen, WE, Antonia, SJ and Gabrilovich, DI (2010). INGN-225: A dendritic cell-based p53 vaccine (Ad.p53-DC) in small cell lung cancer: Observed association between immune response and enhanced chemotherapy effect. Expert Opin Biol Ther 10: 983-991.